Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2023-12-01 00:00:00 ET · period of report 2023-11-30 · accession 0001127602-23-028607 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-01 | 2023-11-30 | BCRX | HEGGIE THERESA | Dir | A - Grant | $5.88 | +956 | 50.9K | +2% | +$5,621 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-30 | A | A | 956 | $5.88 | 50,861 | D | — | — | (F1) Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250. |